Nuveen’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.26B | Sell |
2,019,974
-45,090
| -2% | -$30.7M | 0.3% | 61 |
|
|
2026
Q1 | $1.6B | Buy |
2,065,064
+54,547
| +3% | +$41.8M | 0.43% | 39 |
|
|
2025
Q4 | $1.55B | Buy |
2,010,517
+835,240
| +71% | +$567M | 0.41% | 38 |
|
|
2025
Q3 | $661M | Buy |
1,175,277
+333,728
| +40% | +$189M | 0.17% | 101 |
|
|
2025
Q2 | $442M | Buy |
841,549
+299,531
| +55% | +$167M | 0.12% | 146 |
|
|
2025
Q1 | $344M | Buy |
542,018
+66,388
| +14% | +$45.7M | 0.1% | 176 |
|
|
2024
Q4 | $339M | Sell |
475,630
-211,009
| -31% | -$177M | 0.1% | 180 |
|
|
2024
Q3 | $722M | Buy |
686,639
+84,314
| +14% | +$93.8M | 0.2% | 93 |
|
|
2024
Q2 | $633M | Buy |
602,325
+63,575
| +12% | +$61.6M | 0.19% | 100 |
|
|
2024
Q1 | $519M | Buy |
538,750
+90,281
| +20% | +$85.8M | 0.15% | 125 |
|
|
2023
Q4 | $394M | Buy |
448,469
+52,706
| +13% | +$43.4M | 0.13% | 144 |
|
|
2023
Q3 | $326M | Sell |
395,763
-56,714
| -13% | -$44.6M | 0.11% | 164 |
|
|
2023
Q2 | $325M | Buy |
452,477
+24,581
| +6% | +$19M | 0.11% | 153 |
|
|
2023
Q1 | $352M | Buy |
427,896
+7,597
| +2% | +$5.73M | 0.13% | 149 |
|
|
2022
Q4 | $303M | Buy |
420,299
+36,352
| +9% | +$26.8M | 0.12% | 168 |
|
|
2022
Q3 | $264M | Sell |
383,947
-5,807
| -1% | -$3.65M | 0.11% | 180 |
|
|
2022
Q2 | $230M | Sell |
389,754
-2,280
| -0.6% | -$1.48M | 0.09% | 212 |
|
|
2022
Q1 | $272M | Buy |
392,034
+8,791
| +2% | +$5.56M | 0.09% | 212 |
|
|
2021
Q4 | $242M | Sell |
383,243
-2,830
| -0.7% | -$1.74M | 0.07% | 238 |
|
|
2021
Q3 | $234M | Buy |
386,073
+39,278
| +11% | +$24.4M | 0.07% | 244 |
|
|
2021
Q2 | $194M | Sell |
346,795
-133,453
| -28% | -$67.6M | 0.06% | 305 |
|
|
2021
Q1 | $227M | Sell |
480,248
-353,067
| -42% | -$172M | 0.07% | 248 |
|
|
2020
Q4 | $403M | Sell |
833,315
-792,931
| -49% | -$428M | 0.14% | 141 |
|
|
2020
Q3 | $910M | Sell |
1,626,246
-80,543
| -5% | -$48.8M | 0.35% | 59 |
|
|
2020
Q2 | $1.06B | Buy |
1,706,789
+492,173
| +41% | +$279M | 0.43% | 45 |
|
|
2020
Q1 | $593M | Buy |
1,214,616
+428,361
| +54% | +$177M | 0.29% | 76 |
|
|
2019
Q4 | $295M | Buy |
786,255
+539,224
| +218% | +$181M | 0.11% | 177 |
|
|
2019
Q3 | $68.5M | Sell |
247,031
-105,784
| -30% | -$31.3M | 0.03% | 519 |
|
|
2019
Q2 | $110M | Buy |
352,815
+308,740
| +700% | +$103M | 0.04% | 396 |
|
|
2019
Q1 | $18.1M | Buy |
44,075
+22,244
| +102% | +$9.16M | 0.1% | 319 |
|
|
2018
Q4 | $8.15M | Buy |
21,831
+40
| +0.2% | +$14.6K | 0.05% | 422 |
|
|
2018
Q3 | $8.8M | Buy |
21,791
+2,197
| +11% | +$836K | 0.05% | 455 |
|
|
2018
Q2 | $6.76M | Sell |
19,594
-167
| -0.8% | -$52.2K | 0.04% | 451 |
|
|
2018
Q1 | $6.8M | Sell |
19,761
-21,650
| -52% | -$7.53M | 0.04% | 438 |
|
|
2017
Q4 | $15.6M | Sell |
41,411
-2,825
| -6% | -$1.14M | 0.1% | 304 |
|
|
2017
Q3 | $19.8M | Buy |
44,236
+22,128
| +100% | +$10.5M | 0.13% | 247 |
|
|
2017
Q2 | $10.9M | Sell |
22,108
-2,168
| -9% | -$949K | 0.07% | 390 |
|
|
2017
Q1 | $9.41M | Buy |
24,276
+4,389
| +22% | +$1.63M | 0.06% | 431 |
|
|
2016
Q4 | $7.3M | Sell |
19,887
-327
| -2% | -$124K | 0.04% | 538 |
|
|
2016
Q3 | $8.13M | Buy |
20,214
+89
| +0.4% | +$35.7K | 0.05% | 437 |
|
|
2016
Q2 | $7.03M | Sell |
20,125
-386
| -2% | -$149K | 0.04% | 436 |
|
|
2016
Q1 | $7.39M | Sell |
20,511
-10,166
| -33% | -$4.19M | 0.04% | 398 |
|
|
2015
Q4 | $16.7M | Buy |
30,677
+170
| +0.6% | +$92.1K | 0.09% | 245 |
|
|
2015
Q3 | $14.2M | Buy |
30,507
+19
| +0.1% | +$10.2K | 0.08% | 276 |
|
|
2015
Q2 | $15.6M | Sell |
30,488
-3,882
| -11% | -$1.89M | 0.08% | 291 |
|
|
2015
Q1 | $15.5M | Buy |
34,370
+5,109
| +17% | +$2.17M | 0.09% | 309 |
|
|
2014
Q4 | $12M | Sell |
29,261
-6,334
| -18% | -$2.49M | 0.07% | 352 |
|
|
2014
Q3 | $12.8M | Sell |
35,595
-1,465
| -4% | -$491K | 0.08% | 331 |
|
|
2014
Q2 | $10.5M | Sell |
37,060
-13,032
| -26% | -$3.86M | 0.06% | 360 |
|
|
2014
Q1 | $15M | Sell |
50,092
-18,140
| -27% | -$5.59M | 0.09% | 281 |
|
|
2013
Q4 | $18.8M | Sell |
68,232
-6,707
| -9% | -$1.93M | 0.12% | 244 |
|
|
2013
Q3 | $23.4M | Sell |
74,939
-20,003
| -21% | -$5.26M | 0.15% | 188 |
|
|
2013
Q2 | $21.4M | Buy |
+94,942
| New | +$22.1M | 0.14% | 198 |
|
Other funds holding REGN
Nuveen's REGN Position: Q2 2026 in Review
Nuveen reduced its Regeneron Pharmaceuticals (REGN) stake by 2.2% in Q2 2026, selling an estimated $30.7M and leaving 2,019,974 shares worth $1.26B. The position accounts for 0.3% of the portfolio, ranked #61.
Nuveen first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.6B in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Nuveen held 2,019,974 shares of Regeneron Pharmaceuticals worth $1.26B as of Q2 2026.
- Nuveen sold 45,090 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $30.7M.
- Regeneron Pharmaceuticals made up 0.3% of Nuveen's portfolio in Q2 2026, its #61 holding.
- Nuveen first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Regeneron Pharmaceuticals position peaked at $1.6B in Q1 2026.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.